Continuous Superior to Intermittent ADT, Study Finds

Share this content:

A large, international trial has found intermittent androgen deprivation therapy (ADT) is not equivalent to continuous ADT. 

John Schieszer reports in today's Medical Minute on a study that included 1,535 patients with metastatic prostate cancer and followed for a median of 10 years.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters